Hrt Financial LP Palatin Technologies Inc Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.5 $9,301 - $17,225	34,451 New	34,451 $9,000
Q4 2020 Feb 16, 2021	SELL	$0.38 - $0.78 $16,028 - $32,900	-42,180 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$0.47 - $0.64 $133,363 - $181,601	-283,752 Reduced 87.06%	42,180 $19,000
Q2 2020 Aug 14, 2020	BUY	$0.41 - $0.73 $129,304 - $230,225	315,378 Added 2988.23%	325,932 $166,000
Q1 2020 May 15, 2020	BUY	$0.36 - $0.79 $3,799 - $8,337	10,554 New	10,554 $4,000
Q4 2019 Feb 14, 2020	SELL	$0.75 - $0.89 $25,207 - $29,912	-33,610 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.78 - $1.09 $26,215 - $36,634	33,610 New	33,610 $30,000
Q4 2018 Feb 15, 2019	SELL	$0.63 - $1.0 $36,926 - $58,613	-58,613 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$0.88 - $1.1 $51,579 - $64,474	58,613 New	58,613 $58,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.01M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.